BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31036108)

  • 1. Comparison of Efficiency of TACE plus HIFU and TACE alone on Patients with Primary Liver Cancer.
    Luo Y; Jiang Y
    J Coll Physicians Surg Pak; 2019 May; 29(5):414-417. PubMed ID: 31036108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].
    Wu Y; Li J; Zhang SJ; Zhao YF; Zhao LS; Ma XX; Feng LS; Fan ZJ
    Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):691-4. PubMed ID: 23157899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma.
    Zhang S; Zhao Y; He L; Bo C; An Y; Li N; Ma W; Guo Y; Guo Y; Zhang C
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101851. PubMed ID: 34923180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observation of efficacy of TACE combined with HIFU on patients with middle-advanced liver cancer.
    Zhang Q; Bian SQ; Lv W; Kou D; Hu HL; Guo SS; Cao ZS
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):239-246. PubMed ID: 31389607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.
    Li C; Zhang W; Zhang R; Zhang L; Wu P; Zhang F
    Eur J Cancer; 2010 Sep; 46(13):2513-21. PubMed ID: 20663659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
    Yuan P; Zhang Z; Kuai J
    J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy--preliminary observations.
    Kim J; Chung DJ; Jung SE; Cho SH; Hahn ST; Lee JM
    Br J Radiol; 2012 Oct; 85(1018):e940-6. PubMed ID: 22553305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
    Lu B; Zhu L; Wang X; Zhong L; Cheng Y; Fan J; Yu L
    J BUON; 2019; 24(5):1979-1984. PubMed ID: 31786864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter Arterial Chemoembolisation Combined with Radiofrequency Ablation on Hepatocellular Carcinoma and Levels of Relevant Markers.
    Feng J; Yang JH; Li JH; Jin XS; Sun Q
    J Coll Physicians Surg Pak; 2020 Mar; 30(3):259-262. PubMed ID: 32169132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
    Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
    Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
    Cheung TT; Poon RT; Jenkins CR; Chu FS; Chok KS; Chan AC; Tsang SH; Dai WC; Yau TC; Chan SC; Fan ST; Lo CM
    Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation.
    Chok KS; Cheung TT; Lo RC; Chu FS; Tsang SH; Chan AC; Sharr WW; Fung JY; Dai WC; Chan SC; Fan ST; Lo CM
    Liver Transpl; 2014 Aug; 20(8):912-21. PubMed ID: 24753206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on transcatheter arterial chemoembolization, portal vein embolization and high intensity focused ultrasound sequential therapy for patients.
    Cui L; Liu XX; Jiang Y; Wu XJ; Liu JJ; Zhou XR; He XJ; Huang XE
    Asian Pac J Cancer Prev; 2012; 13(12):6257-61. PubMed ID: 23464441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis.
    Jin C; Zhu H; Wang Z; Wu F; Chen W; Li K; Su H; Zhou K; Gong W
    Eur J Radiol; 2011 Dec; 80(3):662-9. PubMed ID: 20864286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L; Li HL; Guo CY; Luo SX
    Korean J Radiol; 2018; 19(2):237-246. PubMed ID: 29520181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.